Murillo-Llanes J, Soto-Valenzuela H, Flores-Flores P, Peraza-Garay F

Language: Spanish
References: 15
Page: 485-491
PDF size: 184.54 Kb.

ABSTRACT

Objective: To describe the clinical and epidemiological characteristics of dengue fever (DF) and dengue hemorrhagic fever (DHF).
Material and methods: A cross-sectional study was conducted in the Hospital General de Culiacan “Dr. Bernardo J. Gastélum” and the Hospital General de Zona 28 of IMSS from September to November 2003, with patients having dengue diagnosis, which was classified according to the WHO criteria. The statistical program Stata v6 was used for the analysis.
Results: 231 dengue cases (DF: 90.48 %; DHF 9.52 %) were included. average age was 34.5 ± 15 years. 61.7% of DF cases were women, while 77.3% of DHF cases were men. DHF cases went to the hospital in 4.7 ± 2 days, while DF cases went in 3.4 ± 2.2 days (p = 0.004). DHF cases had more often headache, retroocular pain, arthralgias, diarrhea and vomiting (p ‹ 0.05). DF cases showed hemorrhagic manifestations (24.8%); plasma leakage (6.7%) and thrombocytopenia (34.4%); petequiae, gingival bleeding and epistaxis were associated to thrombocytopenia below 39 000/mm³ (p ‹ 0.05); neutropenia, prolonged partial thromboplastin time elevated transaminases were observed more often in DHF cases (p ‹0.05).
Conclusions: the main variables associated with DHF were: male gender, fever, vomiting and gingival bleeding but not previous history of dengue; the major hemoconcentration, the major severity of thrombocytopenia.

REFERENCES

1. Kautner I, Robinson M, Kuhnl U. Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention. J Pediatr 1997;131(4):516-524.

2. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J 2004;80(948):588-601.

3. Wills BA, Oragui EE, Daramola OA, Minh Dung N, Thi-Loan H, Vinh-Chau N, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis 2002;35:277-285.

4. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998;11:480-496.

5. Huan-Yao L, Trai-Ming Y, Hsiao-Sheng L, Yee-Shin L, Shun-Hau C, Ching-Chuan L. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001;8:377-388.

6. Boletín Epidemiológico de la OPS 2000;21:2.

7. Información del Departamento de Epidemiología de la SSA del Estado de Sinaloa, Noviembre de 2003.

8. Rodríguez AO, Pérez-Pérez A, Despaigne-Bicet A, Irarragiri-Dorado CA. Caracterización de pacientes con diagnóstico presuntivo de dengue en el brote epidémico del año 1997. Rev Cub Med Trop 2001;53(1):24-27.

9. Wu KL, Changchien CS, Kuo CH, Chiu KW, Lu SN, et al. Early abdominal sonographic findings in patients with dengue fever. J Clin Ultrasound 2004;32(8):386.

10. Lum LC, Goh AY, Chan PW, EI-Amin AL, Lam SK. Risk factors for hemorrhagic in severe dengue infections. J Pediatr 2002;140(5): 629-631.

11. Gomber S, Ramachandran VG, Kumar S, Agarwal KN, Gupta P, et al. Hematological observations as diagnostic markers in dengue hemorrhagic fever-a reappraisal. Indian Pediatrics 2001; 38(5):477-481.

12. Oishi K, Inoue S, Cinco MT, Dimaano E, Alera M, Alfon J, et al. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infection. J Med Virol 2003;71(2):259-264.

13. Krishnamurti C, Peat RA, Cutting MA, Rothwell SW. Platelet adhesion to dengue-2 virus infected endothelial cells. Am J Trop Med Hyg 2002;66(4): 435-441.

14. Levi M, ten Cate H, van der Poll T. Endothelium: interface between coagulation and inflammation. Crit Care Med 2002;30(Suppl 5):S220-S224.

15. Juffrie M, Meer GM, Hack CE, Haasnoot K, Veerman AJ, Thijs LG. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C reactive protein and secretory phospholipase A2. Am J Trop Med Hyg 2001;65(1):70-75.